V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280004474 | 280003092 | 1.79 | 77.9 | Palliative (P) | 2015-08-23 | 2015-08-26 | CARBOPLATIN + RT | N | Y | 280027400 | CARBOPLATIN + RT |
| 280004475 | 280009858 | 1.76 | 76 | null | 2014-12-06 | 2014-12-20 | EOX | N | N | 280027403 | EOX |
| 280004476 | 280003093 | 1.68 | 73.9 | Curative (C) | 2016-06-16 | 2016-06-17 | CARBOPLATIN + ETOPOSIDE | N | Y | 280027404 | CARBOPLATIN + ETOPOSIDE |
| 280004477 | 280003093 | 1.7 | 87.8 | Curative (C) | 2013-12-22 | 2013-12-22 | CETUXIMAB | 02 | null | 280027404 | CETUXIMAB |
| 280004478 | 280003094 | 1.63 | 78.5 | Curative (C) | 2013-08-05 | 2013-08-05 | STS Rhabdomyosarcoma RMS 2005 IVAVV | N | N | 280027407 | NOT MATCHED |
| 280004479 | 280003095 | 1.7 | 74.2 | Adjuvant (A) | 2014-06-27 | 2014-06-30 | Carboplatin + Etoposide iv&po | 02 | N | 280027410 | CARBOPLATIN + ETOPOSIDE |
| 280004480 | 280003095 | 0 | 96.5 | Curative (C) | 2014-10-24 | 2014-11-10 | null | 2 | N | 280027410 | NOT MATCHED |
| 280004481 | 280003096 | 1.54 | null | Neo-adjuvant (N) | 2013-12-24 | 2013-12-24 | CISPLATIN + GEMCITABINE | 2 | Y | 280027421 | CISPLATIN + GEMCITABINE |
| 280004482 | 280003096 | 1.71 | 88 | Curative (C) | 2016-04-28 | 2016-05-19 | Carboplatin + Paclitaxel (3 weekly) | N | N | 280027421 | CARBOPLATIN + PACLITAXEL |
| 280004483 | 280003097 | 0 | 75 | Palliative (P) | 2015-12-14 | 2015-12-21 | STS Rhabdomyosarcoma RMS 2005 IVAVV | N | Y | 280027424 | NOT MATCHED |
| 280004484 | 280003098 | 1.5 | 58.6 | Curative (C) | null | 2016-01-04 | CETUXIMAB | Y | null | 280027425 | CETUXIMAB |
| 280004485 | 280007570 | 0 | 71.6 | Curative (C) | 2013-12-04 | 2013-12-11 | STS Rhabdo RMS 2005 | N | N | 280027428 | NOT MATCHED |
| 280004486 | 280007570 | 1.66 | 73.9 | Curative (C) | 2015-01-31 | 2015-02-02 | CARBOPLATIN + RT | Y | Y | 280027428 | CARBOPLATIN + RT |
| 280004487 | 280003099 | 1.76 | null | Neo-adjuvant (N) | 2014-07-27 | 2014-08-24 | Carboplatin + Paclitaxel (3 weekly) | Y | N | 280027434 | CARBOPLATIN + PACLITAXEL |
| 280004488 | 280003100 | 1.56 | 60 | Curative (C) | 2013-07-10 | 2013-07-11 | EOX | 02 | N | 280027435 | EOX |
| 280004489 | 280003101 | 1.65 | 62.2 | Curative (C) | 2014-10-03 | 2014-10-05 | CETUXIMAB | Y | Y | 280027437 | CETUXIMAB |
| 280004490 | 280003101 | 1.76 | 70.2 | Adjuvant (A) | 2013-06-01 | 2013-06-22 | EOX | 02 | N | 280027437 | EOX |
| 280004491 | 280003101 | 1.79 | 78.7 | Curative (C) | 2015-09-02 | 2015-09-05 | Cetuximab 7 day (Cycle 1) | Y | N | 280027437 | CETUXIMAB |
| 280004492 | 280010990 | 1.62 | null | Palliative (P) | 2015-07-18 | 2015-07-21 | Trial Unspecified | 02 | N | 280027444 | TRIAL |
| 280004493 | 280011558 | 1.65 | 68.8 | Palliative (P) | 2017-04-12 | 2017-04-28 | Cetuximab 7 day (Cycle 1) | Y | N | 280027445 | CETUXIMAB |
| 280004494 | 280011558 | 1.68 | 54 | Palliative (P) | 2015-08-21 | 2015-09-15 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 280027445 | CISPLATIN + GEMCITABINE |
| 280004495 | 280003102 | 0 | 59 | Neo-adjuvant (N) | 2017-11-10 | 2017-11-18 | NB Low/Interm risk guidelines Carbo/Etop | N | N | 280027451 | NOT MATCHED |
| 280004496 | 280003103 | 1.63 | 77.3 | null | 2013-02-11 | 2013-03-01 | Carboplatin + Paclitaxel (3 weekly) | N | N | 280027452 | CARBOPLATIN + PACLITAXEL |
| 280004497 | 280003104 | 1.5 | 69.2 | Palliative (P) | 2016-12-14 | 2016-12-24 | Carboplatin + Etoposide iv&po | 2 | N | 280027454 | CARBOPLATIN + ETOPOSIDE |
| 280004498 | 280003104 | 2 | 77 | Curative (C) | 2015-05-24 | 2015-06-23 | Carboplatin AUC 6 - 10 | 02 | Y | 280027454 | CARBOPLATIN |
| 280004499 | 280003105 | 1.78 | 110 | Neo-adjuvant (N) | 2013-05-28 | 2013-05-28 | CARBOPLATIN + RT | N | null | 280027456 | CARBOPLATIN + RT |
| 280004500 | 280003105 | 1.68 | 73 | Palliative (P) | 2017-10-20 | 2017-10-31 | Carboplatin AUC 2 - 5 | N | N | 280027456 | CARBOPLATIN |
| 280004501 | 280009861 | null | 81.3 | Curative (C) | 2018-06-14 | 2018-06-26 | Carboplatin + Paclitaxel (3 weekly) | N | Y | 280027458 | CARBOPLATIN + PACLITAXEL |
| 280004502 | 280009861 | 2 | 78 | Curative (C) | 2017-09-09 | 2017-10-16 | Carboplatin AUC 2 - 5 | N | Y | 280027458 | CARBOPLATIN |
| 280004503 | 280009861 | 1.87 | 86.3 | Curative (C) | 2013-05-28 | 2013-06-26 | Cetuximab 14 day | N | null | 280027458 | CETUXIMAB |
| 280004504 | 280003106 | 1.64 | 63.2 | Palliative (P) | 2015-06-11 | 2015-06-16 | Carboplatin + Paclitaxel (3 weekly) | 02 | Y | 280027463 | CARBOPLATIN + PACLITAXEL |
| 280004505 | 280007574 | 1.77 | null | Adjuvant (A) | 2013-12-27 | 2013-12-27 | Cisplatin+Gemcitabine (gallbladder) | null | null | 280027464 | CISPLATIN + GEMCITABINE |
| 280004506 | 280003107 | 1.66 | 10 | Curative (C) | 2018-02-18 | 2018-02-21 | Trial Unspecified | Y | N | 280027465 | TRIAL |
| 280004507 | 280003107 | 1.74 | 64.6 | Curative (C) | 2014-08-03 | 2014-08-11 | Carboplatin + Paclitaxel (3 weekly) | N | Y | 280027465 | CARBOPLATIN + PACLITAXEL |
| 280004508 | 280003107 | 1.57 | 116 | Curative (C) | 2016-05-19 | 2016-05-27 | EOX | Y | Y | 280027465 | EOX |
| 280004509 | 280003107 | 1.71 | 68.8 | null | 2016-11-25 | 2016-11-25 | CARBOPLATIN + RT | N | Y | 280027465 | CARBOPLATIN + RT |
| 280004510 | 280003107 | null | 80.3 | Curative (C) | 2015-09-11 | 2015-09-12 | Carboplatin + Etoposide iv&po | 02 | N | 280027465 | CARBOPLATIN + ETOPOSIDE |
| 280004511 | 280011830 | 1.56 | null | null | 2014-10-24 | 2014-11-21 | EW EuroEwing 2012 Arm B VDC | Y | Y | 280027473 | TRIAL |
| 280004512 | 280011830 | 1.63 | 147 | Neo-adjuvant (N) | 2017-08-21 | 2017-09-04 | Carboplatin + Paclitaxel (3 weekly) | null | N | 280027473 | CARBOPLATIN + PACLITAXEL |
| 280004513 | 280003108 | 1.88 | 58 | Palliative (P) | 2016-10-15 | 2016-10-15 | Trial Unspecified | null | N | 280027478 | TRIAL |
| 280004514 | 280003108 | 1.84 | 104.6 | Curative (C) | 2016-09-28 | 2016-09-29 | CARBOPLATIN + ETOPOSIDE | 02 | Y | 280027478 | CARBOPLATIN + ETOPOSIDE |
| 280004515 | 280003109 | 1.61 | 63 | null | 2016-09-03 | 2016-09-08 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | N | 280027482 | CISPLATIN + GEMCITABINE |
| 280004516 | 280003109 | 1.82 | 107 | Neo-adjuvant (N) | 2014-05-03 | 2014-05-08 | Carboplatin AUC 2 - 5 | 02 | N | 280027482 | CARBOPLATIN |
| 280004517 | 280003109 | null | 82 | Neo-adjuvant (N) | 2017-11-12 | 2017-11-18 | CARBOPLATIN | N | Y | 280027482 | CARBOPLATIN |
| 280004518 | 280003110 | 0 | 80.3 | Curative (C) | 2016-03-21 | 2016-04-12 | CETUXIMAB | 2 | N | 280027487 | CETUXIMAB |
| 280004519 | 280003110 | 1.59 | 17.6 | Curative (C) | 2017-02-28 | 2017-09-19 | EOX | N | Y | 280027487 | EOX |
| 280004520 | 280003111 | 1.83 | 78.7 | null | 2016-06-30 | 2016-07-03 | Trial Unspecified | 02 | N | 280027490 | TRIAL |
| 280004521 | 280003112 | 1.72 | 69.9 | Curative (C) | 2013-11-12 | 2013-11-12 | Cisplatin + Gemcitabine (D 1 & 8) | N | Y | 280027491 | CISPLATIN + GEMCITABINE |
| 280004522 | 280003112 | 1.62 | null | Neo-adjuvant (N) | 2016-05-11 | 2016-05-18 | Cetuximab 7 day (Cycle 1) | N | N | 280027491 | CETUXIMAB |
| 280004523 | 280003113 | 1.5 | null | Curative (C) | 2017-09-08 | 2017-09-12 | EOX | N | N | 280027494 | EOX |